Welcome to MENACTRIMS

Middle East North Africa Committee for Research and Treatment in Multiple Sclerosis

icon1

About MENACTRIMS

MENACTRIMS is an independent organization that facilitates communication and creates synergies among clinicians and scientists to promote and enhance research and improve clinical outcomes in multiple sclerosis (MS).

icon2

MENACTRIMS Guidelines

Multiple Sclerosis (MS) is a chronic demyelinating disorder of the central nervous system (CNS) that affects predominately patients aged 20-40 years.

About MENACTRIMS

MENACTRIMS is an independent organization that facilitates communication and creates synergies among clinicians and scientists to promote and enhance research and improve clinical outcomes in multiple sclerosis (MS). The main objectives of the organization are as follows:

  • To establish National and Regional MS registries and to collaborate database in order to formulate a large MS registry
  • To develop regular updated guidelines pertaining to diagnosis and therapy of MS in this region
  • To organize at least bi-annual congresses in the field of treatment and research in multiple sclerosis
  • To encourage young researchers in the field of multiple sclerosis.
  • To collaborate with relevant national and local associations in the region to enhance MENACTRIMS mission.
  • To establish National and Regional MS registries and to collaborate database in order to formulate a large MS registry
  • To develop regular updated guidelines pertaining to diagnosis and therapy of MS in this region
  • To organize at least bi-annual congresses in the field of treatment and research in multiple sclerosis
  • To encourage young researchers in the field of multiple sclerosis.
  • To collaborate with relevant national and local associations in the region to enhance MENACTRIMS mission.

MENACTRIMS is a non-profit organization registered in Amman-Jordan.